BACKGROUND: Adverse drug events (ADE) contribute significantly to hospital admissions. Prospective New Zealand data are scant, and the ability of clinical coding to identify ADE associated admissions is uncertain. Outcomes after cessation of causative medications are unknown. AIMS: To assess the frequency, nature and causality of ADE associated with acute admissions to General Medicine at Christchurch Hospital. METHODS: Prospective observational study of patients admitted to our medical team over 20 weeks. RESULTS: Of 336 admissions, 96 (28.6%) were ADE related. Sixty-five (19.3%) were caused by an ADE, and 31 (9.2%) were contributed to by an ADE. The mean age of non-ADE patients was 64.3 years (range 16-91), which was similar to the mean age of ADE patients (65.9 years; 21-92). However, if intentional overdoses and recreational drug use were excluded, ADE patients were significantly older at 72.4 years (21-92) (P = 0.0007). ADE patients took more regular medications on admission (mean 6.6, range 0-22) than non-ADE patients (mean 5.0, 0-18), (P = 0.003). The average length of stay was similar. The commonest medications implicated were vasodilators, psychotropics and diuretics. The most common adverse effects were postural hypotension and/or vasovagal syncope (29% of ADE), intentional overdoses and recreational drug use (15%) and acute renal failure and/or clinical dehydration (10%). Seventy-six patients had culprit medications stopped or reduced, and this potentially contributed to six readmissions. Coding identified 61% of ADE associated admissions. CONCLUSION: ADE are a common cause of hospital admission. The most frequent problems are postural hypotension and vasovagal syncope, intentional drug misuse and dehydration.
BACKGROUND: Adverse drug events (ADE) contribute significantly to hospital admissions. Prospective New Zealand data are scant, and the ability of clinical coding to identify ADE associated admissions is uncertain. Outcomes after cessation of causative medications are unknown. AIMS: To assess the frequency, nature and causality of ADE associated with acute admissions to General Medicine at Christchurch Hospital. METHODS: Prospective observational study of patients admitted to our medical team over 20 weeks. RESULTS: Of 336 admissions, 96 (28.6%) were ADE related. Sixty-five (19.3%) were caused by an ADE, and 31 (9.2%) were contributed to by an ADE. The mean age of non-ADE patients was 64.3 years (range 16-91), which was similar to the mean age of ADE patients (65.9 years; 21-92). However, if intentional overdoses and recreational drug use were excluded, ADE patients were significantly older at 72.4 years (21-92) (P = 0.0007). ADE patients took more regular medications on admission (mean 6.6, range 0-22) than non-ADE patients (mean 5.0, 0-18), (P = 0.003). The average length of stay was similar. The commonest medications implicated were vasodilators, psychotropics and diuretics. The most common adverse effects were postural hypotension and/or vasovagal syncope (29% of ADE), intentional overdoses and recreational drug use (15%) and acute renal failure and/or clinical dehydration (10%). Seventy-six patients had culprit medications stopped or reduced, and this potentially contributed to six readmissions. Coding identified 61% of ADE associated admissions. CONCLUSION: ADE are a common cause of hospital admission. The most frequent problems are postural hypotension and vasovagal syncope, intentional drug misuse and dehydration.
Authors: Amaia Malet-Larrea; Estíbaliz Goyenechea; Victoria García-Cárdenas; Begoña Calvo; Jose M Arteche; Pedro Aranegui; Jose J Zubeldia; Miguel A Gastelurrutia; Fernando Martínez-Martínez; Shalom I Benrimoj Journal: Br J Clin Pharmacol Date: 2016-06-09 Impact factor: 4.335
Authors: Sharon Leitch; Susan M Dovey; Wayne K Cunningham; Alesha J Smith; Jiaxu Zeng; David M Reith; Katharine A Wallis; Kyle S Eggleton; Andrew W McMenamin; Martyn I Williamson; Steven Lillis Journal: Br J Gen Pract Date: 2021-07-29 Impact factor: 6.302
Authors: Jonas Kindstedt; Sofia Svahn; Maria Sjölander; Eva-Lotta Glader; Hugo Lövheim; Maria Gustafsson Journal: BMJ Open Date: 2020-04-27 Impact factor: 2.692
Authors: A E M J H Linkens; V Milosevic; P H M van der Kuy; V H Damen-Hendriks; C Mestres Gonzalvo; K P G M Hurkens Journal: Int J Clin Pharm Date: 2020-05-30
Authors: Logan T Murry; Michelle S Keller; Joshua M Pevnick; Jeffrey L Schnipper; Korey A Kennelty Journal: BMC Health Serv Res Date: 2022-02-12 Impact factor: 2.908
Authors: Lisbeth Damlien Nymoen; Trude Eline Flatebø; Tron Anders Moger; Erik Øie; Espen Molden; Kirsten Kilvik Viktil Journal: PLoS One Date: 2022-09-19 Impact factor: 3.752